Pronucleotein Biotechnologies Overview

  • Founded
  • 2005
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 2

Pronucleotein Biotechnologies General Information

Description

Developer of deoxyribonucleic acid aptamer sequences and conjugates. The company's diagnostic platform for development and commercialization of a new food safety testing system can be used at any point in the global food supply chain, and provide results onsite within 30 minutes.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Services
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 4100 North West Loop 410
  • Suite 230
  • San Antonio, TX 78229
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Pronucleotein Biotechnologies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pronucleotein Biotechnologies‘s full profile, request access.

Request a free trial

Pronucleotein Biotechnologies Executive Team (4)

Name Title Board Seat Contact Info
John Millice President
John Bruno Ph.D Vice President & Chief Technology Officer
Lynda de la Vina Co-Founder & Director
To view Pronucleotein Biotechnologies’s complete executive team members history, request access »

Pronucleotein Biotechnologies Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Pronucleotein Biotechnologies‘s full profile, request access.

Request a free trial